Shanghai RAAS Blood Products Co Ltd Class A Cash Flow Conversion Efficiency

Latest as of December 2025: -0.026x

Shanghai RAAS Blood Products Co Ltd Class A cash flow conversion efficiency. Based on the latest financial reports, Shanghai RAAS Blood Products Co Ltd Class A (002252) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-843.75 Million ≈ $-123.47 Million USD) by net assets (CN¥32.46 Billion ≈ $4.75 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)

Cash flow conversion efficiency of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025. This chart illustrates how Shanghai RAAS Blood Products Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002252 stock price and chart for real-time trading data and today's change.

Shanghai RAAS Blood Products Co Ltd Class A Cash Flow Conversion Ratio Explained

Shanghai RAAS Blood Products Co Ltd Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanghai RAAS Blood Products Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai RAAS Blood Products Co Ltd Class A ranked by their cash flow conversion efficiency. Also see Shanghai RAAS Blood Products Co Ltd Clas market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Cousins Properties Incorporated NYSE:CUZ	0.035x
Steadfast Group Ltd AU:SDF	0.106x
Investec PLC JSE:INP	-0.202x
United Plantations Bhd KLSE:2089	0.337x
Synaptics Incorporated NASDAQ:SYNA	0.016x
Hangcha Group Co Ltd SHG:603298	0.026x
Crescent Energy Co NYSE:CRGY	0.137x
Huadian Energy SHG:600726	0.009x

Annual Cash Flow Conversion Efficiency for Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025. Review how much free cash does Shanghai RAAS Blood Products Co Ltd Clas generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥32.47 Billion ≈ $4.75 Billion	CN¥-104.89 Million ≈ $-15.35 Million	-0.003x	+78.59%
2024-12-31	CN¥31.94 Billion ≈ $4.67 Billion	CN¥-482.06 Million ≈ $-70.54 Million	-0.015x	-119.64%
2023-12-31	CN¥29.65 Billion ≈ $4.34 Billion	CN¥2.28 Billion ≈ $333.33 Million	0.077x	+28.28%
2022-12-31	CN¥28.81 Billion ≈ $4.22 Billion	CN¥1.73 Billion ≈ $252.51 Million	0.060x	+19.89%
2021-12-31	CN¥25.90 Billion ≈ $3.79 Billion	CN¥1.29 Billion ≈ $189.35 Million	0.050x	+7.40%
2020-12-31	CN¥25.13 Billion ≈ $3.68 Billion	CN¥1.17 Billion ≈ $171.04 Million	0.047x	-38.76%
2019-12-31	CN¥11.49 Billion ≈ $1.68 Billion	CN¥872.69 Million ≈ $127.70 Million	0.076x	+215.35%
2018-12-31	CN¥10.90 Billion ≈ $1.60 Billion	CN¥262.50 Million ≈ $38.41 Million	0.024x	+11.83%
2017-12-31	CN¥12.48 Billion ≈ $1.83 Billion	CN¥268.76 Million ≈ $39.33 Million	0.022x	-60.42%
2016-12-31	CN¥11.73 Billion ≈ $1.72 Billion	CN¥638.22 Million ≈ $93.39 Million	0.054x	-23.55%
2015-12-31	CN¥10.71 Billion ≈ $1.57 Billion	CN¥762.42 Million ≈ $111.57 Million	0.071x	+31.73%
2014-12-31	CN¥8.62 Billion ≈ $1.26 Billion	CN¥465.96 Million ≈ $68.18 Million	0.054x	+166.06%
2013-12-31	CN¥1.10 Billion ≈ $161.22 Million	CN¥-90.11 Million ≈ $-13.19 Million	-0.082x	-131.65%
2012-12-31	CN¥1.02 Billion ≈ $149.18 Million	CN¥263.46 Million ≈ $38.55 Million	0.258x	+34.61%
2011-12-31	CN¥927.27 Million ≈ $135.69 Million	CN¥178.03 Million ≈ $26.05 Million	0.192x	-20.29%
2010-12-31	CN¥831.21 Million ≈ $121.63 Million	CN¥200.21 Million ≈ $29.30 Million	0.241x	+58.49%
2009-12-31	CN¥763.33 Million ≈ $111.70 Million	CN¥116.01 Million ≈ $16.98 Million	0.152x	+6.57%
2008-12-31	CN¥754.76 Million ≈ $110.45 Million	CN¥107.64 Million ≈ $15.75 Million	0.143x	-86.20%
2007-12-31	CN¥170.01 Million ≈ $24.88 Million	CN¥175.71 Million ≈ $25.71 Million	1.034x	+202.38%
2006-12-31	CN¥156.77 Million ≈ $22.94 Million	CN¥53.58 Million ≈ $7.84 Million	0.342x	+46.61%
2005-12-31	CN¥231.70 Million ≈ $33.90 Million	CN¥54.02 Million ≈ $7.90 Million	0.233x	--

About Shanghai RAAS Blood Products Co Ltd Class A

SHE:002252 China Biotechnology

Market Cap

$4.56 Billion

CN¥31.18 Billion CNY

Market Cap Rank

#3654 Global

#453 in China

Share Price

CN¥4.73

Change (1 day)

+0.64%

52-Week Range

CN¥4.31 - CN¥6.93

All Time High

CN¥24.72